rekomendacja wypłaty dywidendy - komunikat spółki KRKA, TOVARNA ZDRAVIL D.D. (krka) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		16	/	2025
	Date of issue:		2025-04-03
	Short name of the issuer
	KRKA
	Subject
	Proposed dividend for Krka shareholders 10% higher than last year
	Official market - legal basis
	art. 17. 1 MAR.
	Unofficial market - legal basis
	Contents of the report:
	Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto informs the public on the proposed allocation of the 2024 accumulated profit. The document is attached. The notice will be published on the Company's website (www.krka.biz) from 3 April 2025 onwards, for a minimum period of 5 years.
	Annexes
	File				Description
	Proposed dividend for Krka shareholders.pdf				Proposed dividend for Krka shareholders

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-04-03	Jože Colarič	President of the Management Board and CEO

Nazwa jednostki:	KRKA, TOVARNA ZDRAVIL D.D.
Nazwa skrócona jednoskti:	KRKA
Adres:	Smarjeska 6, 8501 Nove Mesto
Telefon:	+386 7 331 21 11
Fax:	+386 7 332 15 37
NIP:	nie dotyczy